Who We Are

Dr. Heather Preston is a Partner at TPG Biotech based in San Francisco. Prior to joining TPG in 2005, Heather held senior positions at J.P. Morgan Partners, McKinsey & Company, NEA, and in academic medicine. Heather graduated from Oxford and completed her scientific and medical subspecialty training at the Dana Farber Cancer Institute, Massachusetts General Hospital, Harvard, and UCSF. Dr. Preston serves on the Board of Directors of Alder Biotherapeutics (ALDR), Otonomy (OTIC), Albireo, Unchained Labs and Enlibrium, as well as the Fine Art Museums of San Francisco, the Harlech Foundation, and St. Luke’s School.